Related Experiment Video
Updated: May 1, 2026

11:31
Evaluation of the Storage Stability of Extracellular Vesicles
Published on: May 22, 2019
13.8K
Extracellular vesicles: emerging targets for cancer therapy
Pieter Vader1, Xandra O Breakefield2, Matthew J A Wood1
1Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, OX1 3QX, UK.
Trends in Molecular Medicine
|April 8, 2014
Summary
Extracellular vesicles (EVs) mediate intercellular communication in cancer, influencing immune suppression, angiogenesis, and metastasis. Targeting EVs presents a promising strategy for novel anticancer therapies to inhibit tumour growth and spread.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Extracellular vesicles (EVs) are released by nearly all cell types, including tumor cells.
- EVs facilitate intercellular communication by transferring molecular contents, altering recipient cell functions.
- EV-mediated communication plays a critical role in tumor development and progression.
Purpose of the Study:
- To summarize current knowledge on the role of EVs in cancer pathogenesis.
- To discuss novel therapeutic strategies targeting EVs for cancer treatment.
Main Methods:
- Literature review and synthesis of existing research on EVs in cancer.
- Analysis of EV biogenesis and function in the context of cancer progression.
- Exploration of therapeutic potential of targeting EVs.
Main Results:
- EVs contribute to immune suppression, angiogenesis, and metastasis in cancer.
- EVs are involved in various cellular processes crucial for tumor development.
- Targeting EV biogenesis or function is a potential anticancer therapeutic approach.
Conclusions:
- Extracellular vesicles are key mediators of intercellular communication in cancer.
- Targeting extracellular vesicles offers a promising avenue for developing novel anticancer therapies.
- Further research into EV-mediated pathways can lead to innovative strategies for preventing tumor growth and spread.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies
1.4K
1.4K
Overview of Exosomes
2.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K
Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Cancer Therapies
8.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K
Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K

